Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tsc-203-A0201 Human Papillomavirus-Related Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-203-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-203-A0201 Human Papillomavirus-Related Penile Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-203-A0201 Vulvar Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Oropharynx Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Cervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Adenosquamous Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Anal Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Human Papillomavirus-Related Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Human Papillomavirus-Related Penile Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0101 Vulvar Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Oropharynx Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Cervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Adenosquamous Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Anal Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Human Papillomavirus-Related Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Endocervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Human Papillomavirus-Related Penile Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-A0201 Vulvar Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Oropharynx Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Cervical Adenocarcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Adenosquamous Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Anal Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)
Tsc-204-C0702 Human Papillomavirus-Related Squamous Cell Carcinoma	TScan Therapeutics, Inc.	P1	CC (41)

Showing 2026 to 2050 of 3,186 assets

PreviousPage 82 of 128Next